Associations between TFPI-2 methylation and poor prognosis in glioblastomas

Medicina (Lithuania)

Volumn 48, Issue 7, 2012, Pages 345-349

  Vaitkiene, Paulina ^a   Skiriute, Daina ^a   Skauminas, Kȩstutis ^a   Tamašauskas, Arimantas ^a  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

Author keywords

Glioblastoma; Methylation; Survival; Tissue factor pathway inhibitor 2

Indexed keywords

GLYCOPROTEIN; PLACENTA PROTEIN 5; TISSUE-FACTOR-PATHWAY INHIBITOR 2;

ADULT; AGED; ARTICLE; BRAIN TUMOR; DNA METHYLATION; FEMALE; GENETIC EPIGENESIS; GENETICS; GLIOBLASTOMA; HUMAN; MALE; MIDDLE AGED; MORTALITY; PROMOTER REGION; TUMOR CELL CULTURE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GLIOBLASTOMA; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; TUMOR CELLS, CULTURED;

EID: 84872567667     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Adamson C, Kanu OO, Mehta AI, Di C, Lin N, Mattox AK, et al. Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opin Investig Drugs 2009;18(8):1061-83.
2. Konduri SD, Srivenugopal KS, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, et al. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells. Oncogene 2003;22(29):4509-16.
3. Gessler F, Voss V, Seifert V, Gerlach R, Kögel D. Knockdown of TFPI-2 promotes migration and invasion of glioma cells. Neurosci Lett 2011;497(1):49-54.
4. Hubé F, Reverdiau P, Iochmann S, Cherpi-Antar C, Gruel Y. Characterization and functional analysis of TFPI-2 gene promoter in a human choriocarcinoma cell line. Thromb Res 2003;109(4):207-15.
5. Wang S, Xiao X, Zhou X, Huang T, Du C, Yu N, et al.TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma. BMC Cancer 2010;10:617.
6. Wu D, Xiong L, Wu S, Jiang M, Lian G, Wang M. TFPI-2 methylation predicts poor prognosis in non-small cell lung cancer. Lung Cancer 2012;76(1):106-11.
7. Coniglio SJ, Eugenin E, Dobrenis K, Stanley ER, West BL, Symons MH, et al. Microglial stimulation of glioblastoma invasion involves EGFR and CSF-1R signaling. Mol Med 2012;18(1):519-27.
8. Westermarck J, Kähäri VM. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 1999; 13(8):781-92.
9. Park JB, Kwak HJ, Lee SH. Role of hyaluronan in glioma invasion. Cell Adh Migr 2008;2(3):202-7.
10. Ran Y, Pan J, Hu H, Zhou Z, Sun L, Peng L, et al. A novel role for tissue factor pathway inhibitor-2 in the therapy of human esophageal carcinoma. Hum Gene Ther 2009;20(1): 41-9.
11. Sierko E, Wojtukiewicz MZ, Kisiel W. The role of tissue factor pathway inhibitor-2 in cancer biology. Semin Thromb Hemost 2007;33(7):653-9.
12. Hibi K, Goto T, Shirahata A, Saito M, Kigawa G, Nemoto H, et al. Detection of TFPI2 methylation in the serum of colorectal cancer patients. Cancer Lett 2011;311(1):96-100.
13. Hibi K, Goto T, Kitamura YH, Sakuraba K, Shirahata A, Mizukami H, et al. Methylation of the TFPI2 gene is frequently detected in advanced gastric carcinoma. Anticancer Res 2010;30(10):4131-3.
14. Sato N, Parker AR, Fukushima N, Miyagi Y, Iacobuzio- Donahue CA, Eshleman JR, et al. Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma. Oncogene 2005;24(5):850-8.